The Ainsworth Institute is proud to announce is has joined the CREATE-1 Study: CRPS Treatment Evaluation 1 Study – sponsored by Axsome Therapeutics, Inc. This is an FDA approved trial studying the effects of a new groundbreaking oral medication to treat CRPS. Enrollment will start shortly.
- Facebook Live 2 – Full Video - April 2, 2020
- (Full Presentation) Top 5 Things Pain Patients Need To Know During The Coronavirus Pandemic - March 30, 2020
- Top 5 Things Pain Patients Need To Know During The Coronavirus Pandemic - March 26, 2020